Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celtic Pharma Sees a Role for Private Equity in Biotech

This article was originally published in Start Up

Executive Summary

The recently launched private equity firm Celtic Pharma aims to bridge the gap between biotech companies that have trouble financing R&D for mid- to late-stage projects and the Big Pharma firms desperate to rebuild their pipelines. The group's first fund, at around $1 billion, aims to bring together approximately 20 late-stage projects, take each through to regulatory approval, and license them out to the highest bidder.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091013

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel